Larazotide Acetate
Gastrointestinal & peptide biology
Late stageThe main human research context is celiac disease.
Substantial controlled clinical research or late stage development has been identified; this is not a product authorisation claim.
What is Larazotide Acetate?
Larazotide acetate is a synthetic peptide modulator of intestinal tight junction permeability investigated in celiac disease research; the catalogue item denotes the acetate salt research material used in mechanistic and clinical studies.
Which research context has Larazotide Acetate been associated with?
Larazotide Acetate is associated with gastrointestinal research as a synthetic peptide modulator of tight junctions, with primary human studies in celiac disease assessing barrier function modulation and intestinal permeability.
What documentation is available for Larazotide Acetate?
Larazotide Acetate: Batch documents are not yet linked on this site. Required evidence for this synthetic peptide modulator includes batch identifier and release date; identity by liquid chromatography mass spectrometry/intact mass and sequence confirmation; analytical HPLC/UPLC chromatogram with method and purity criteria; peptide content, counterion and residual solvent/water information; and assay or potency data used for release. No batch documentation is shown as available until the record for that specific item is linked and reviewed.
What determines the storage conditions for Larazotide Acetate?
Larazotide Acetate: Storage depends on the documented supplied presentation; as a synthetic peptide modulator of tight junctions verify dry/lyophilised versus solution presentation, counterion and concentration, solvent or buffer composition, pH sensitivity, container closure compatibility and freeze/thaw tolerance which influence aggregation and chemical stability. No storage instruction is shown as available until the stability record for that specific item is linked and reviewed.